Index Performance
Overview
Description
San Diego County boasts a diverse economic landscape that has become fertile ground for several thriving industries, spurred by its strategic location, robust research institutions, and favorable business climate. The region is home to a flourishing [[biotechnology and pharmaceuticals]] sector, anchored by the presence of significant research institutions such as the University of California, San Diego (UCSD) and a nexus of companies in Sorrento Valley and Torrey Pines. Another key driver is the [[defense and military]] industry, as the county hosts major naval bases and benefits from defense contractors investing in advanced technologies. Moreover, San Diego's idyllic climate and scenic attractions have fueled a robust [[tourism and hospitality]] industry. Additionally, the rise of the [[technology and software development]] sector, including cybersecurity and telecommunications, has been drawing an increasing number of startups and established firms to the region. Finally, the proximity to the Mexican border crafts opportunities in [[cross-border trade and logistics]], capitalizing on the synergy of shared economic interests to propel growth. Investors may find potential in these particular subcategories, as they not only represent the backbone of San Diego's economic engine but also stand to benefit from sustained regional support and global economic trends.
- TickerSDCA
- Inception Date11/20/2023
- WeightingMarket Cap
- # of holdings85
What's inside?
Holdings
All holdings as of December 1, 2023
QUALCOMM, Inc. (QCOM) | 36.60% | $145.525B | -24.26% | 55.05% | 3.51x |
Sempra (SRE) | 11.39% | $44.638B | -13.87% | 26.00% | 4.51x |
DexCom, Inc. (DXCM) | 11.21% | $45.283B | 26.69% | 63.75% | 11.55x |
Realty Income Corp. (O) | 9.77% | $39.758B | 24.30% | 45.48% | 14.80x |
ResMed, Inc. (RMD) | 5.79% | $23.674B | 16.00% | 53.30% | 5.28x |
Illumina, Inc. (ILMN) | 4.41% | $17.747B | 0.36% | 61.13% | 5.16x |
LPL Financial Holdings, Inc. (LPLA) | 4.13% | $16.792B | 16.61% | 36.35% | 1.99x |
Neurocrine Biosciences, Inc. (NBIX) | 2.86% | $11.647B | 28.59% | 96.83% | 5.92x |
Halozyme Therapeutics, Inc. (HALO) | 1.34% | $5.271B | 3.38% | 65.21% | 7.90x |
Teradata Corp. (TDC) | 1.16% | $4.652B | 5.04% | 59.36% | 2.68x |
QuidelOrtho Corp. (QDEL) | 1.14% | $4.439B | -5.31% | 42.37% | 2.36x |
Kilroy Realty Corp. (KRC) | 1.06% | $4.191B | 2.77% | 37.58% | 7.33x |
Mirati Therapeutics, Inc. (MRTX) | 1.00% | $3.979B | 201.97% | 84.49% | 49.88x |
ACADIA Pharmaceuticals, Inc. (ACAD) | 0.94% | $3.660B | 61.96% | 93.09% | 4.96x |
WD-40 Co. (WDFC) | 0.78% | $3.220B | 7.69% | 50.39% | 5.59x |
ImmunityBio, Inc. (IBRX) | 0.68% | $2.457B | -30.51% | -5,491.46% | 2,469.82x |
Crinetics Pharmaceuticals, Inc. (CRNX) | 0.55% | $2.238B | N/A | N/A | 1,674.17x |
PriceSmart, Inc. (PSMT) | 0.53% | $2.108B | 9.48% | 17.11% | 0.54x |
Retail Opportunity Investments Corp. (ROIC) | 0.42% | $1.696B | 4.75% | 39.85% | 9.97x |
Jack in the Box, Inc. (JACK) | 0.38% | $1.515B | -7.51% | 25.53% | 2.59x |
Tandem Diabetes Care, Inc. (TNDM) | 0.34% | $1.380B | -9.25% | 48.35% | 1.65x |
Viking Therapeutics, Inc. (VKTX) | 0.34% | $1.737B | N/A | N/A | N/A |
American Assets Trust, Inc. (AAT) | 0.33% | $1.299B | 0.16% | 35.99% | 7.10x |
Encore Capital Group, Inc. (ECPG) | 0.27% | $1.077B | -2.06% | 62.49% | 3.51x |
Ligand Pharmaceuticals, Inc. (LGND) | 0.25% | $1.039B | -50.27% | 64.54% | 5.58x |
Petco Health & Wellness Company, Inc. (WOOF) | 0.20% | $775.014M | -0.47% | 36.81% | 0.61x |
Kura Oncology, Inc. (KURA) | 0.19% | $802.139M | N/A | N/A | N/A |
Maravai Lifesciences Holdings, Inc. (MRVI) | 0.18% | $688.703M | -65.04% | 44.09% | 4.12x |
Arcturus Therapeutics Holdings, Inc. (ARCT) | 0.18% | $613.568M | 224.45% | 98.16% | 1.31x |
Avidity Biosciences, Inc. (RNA) | 0.15% | $572.062M | 13.54% | 53.87% | -5.85x |
Mitek Systems, Inc. (MITK) | 0.13% | $517.442M | 9.50% | 85.81% | 2.93x |
Travere Therapeutics, Inc. (TVTX) | 0.12% | $556.079M | -30.66% | 65.59% | 2.16x |
ARS Pharmaceuticals, Inc. (SBTX) | 0.12% | $500.146M | N/A | N/A | 90.96x |
Janux Therapeutics, Inc. (JANX) | 0.11% | $430.290M | 38.83% | 80.14% | 16.05x |
AnaptysBio, Inc. (ANAB) | 0.10% | $431.581M | 156.61% | 82.16% | 26.29x |
Fate Therapeutics, Inc. (FATE) | 0.07% | $233.687M | -87.02% | -143.83% | -0.34x |
Poseida Therapeutics, Inc. (PSTX) | 0.07% | $285.917M | -91.96% | 84.56% | 1.33x |
Erasca, Inc. (ERAS) | 0.06% | $264.402M | N/A | N/A | N/A |
Guild Holdings Co. (GHLD) | 0.06% | $250.827M | 11.61% | 94.87% | 3.34x |
Reneo Pharmaceuticals, Inc. (RPHM) | 0.06% | $230.518M | N/A | N/A | N/A |
Gossamer Bio, Inc. (GOSS) | 0.05% | $232.172M | N/A | N/A | N/A |
TuSimple Holdings, Inc. (TSP) | 0.05% | $222.362M | -100.00% | N/A | -171.51x |
Heron Therapeutics, Inc. (HRTX) | 0.05% | $217.605M | 18.36% | 42.08% | 2.05x |
Ventyx Biosciences, Inc. (VTYX) | 0.03% | $124.592M | N/A | N/A | N/A |
Kinnate Biopharma, Inc. (KNTE) | 0.03% | $105.061M | N/A | N/A | N/A |
Heritage Global, Inc. (HGBL) | 0.03% | $101.796M | 22.83% | 61.62% | 1.93x |
Capricor Therapeutics, Inc. (CAPR) | 0.02% | $101.616M | 288.66% | 95.53% | 4.67x |
Longboard Pharmaceuticals, Inc. (LBPH) | 0.02% | $85.746M | N/A | N/A | N/A |
BioAtla, Inc. (BCAB) | 0.02% | $66.925M | N/A | N/A | N/A |
Beam Global (BEEM) | 0.02% | $75.851M | 149.37% | 1.72% | 1.62x |
aTyr Pharma, Inc. (LIFE) | 0.02% | $73.200M | N/A | -181.30% | 0.41x |
Cidara Therapeutics, Inc. (CDTX) | 0.02% | $70.538M | -68.79% | 94.76% | 0.72x |
Genasys, Inc. (GNSS) | 0.02% | $69.226M | 0.78% | 46.94% | 1.82x |
Bionano Genomics, Inc. (BNGO) | 0.02% | $64.087M | 29.04% | 29.50% | 1.57x |
Cardiff Oncology, Inc. (CRDF) | 0.01% | $59.421M | 51.61% | 24.11% | -36.88x |
Cue Health, Inc. (HLTH) | 0.01% | $50.874M | -74.89% | -26.91% | 0.03x |
DermTech, Inc. (DMTK) | 0.01% | $56.843M | 9.57% | 4.39% | 2.48x |
MEI Pharma, Inc. (MEIP) | 0.01% | $43.442M | 647.96% | 99.30% | -0.22x |
Daré Bioscience, Inc. (DARE) | 0.01% | $34.487M | N/A | 99.07% | 28.35x |
Franklin Wireless Corp. (FKWL) | 0.01% | $35.117M | 19.07% | 15.55% | 0.12x |
Murphy Canyon Acquisition Corp. (MURF) | 0.01% | N/A | N/A | N/A | N/A |
Sonim Technologies, Inc. (SONM) | 0.01% | $29.809M | 34.49% | 20.33% | 0.18x |
Biora Therapeutics, Inc. (PROG) | 0.01% | $27.733M | -100.00% | N/A | 5,690.31x |
Singular Genomics Systems, Inc. (OMIC) | 0.01% | $28.980M | N/A | -418.83% | -33.08x |
Sorrento Therapeutics, Inc. (SRNE) | 0.01% | $23.540M | 31.10% | 36.24% | 5.16x |
Regulus Therapeutics, Inc. (RGLS) | 0.01% | $27.301M | N/A | N/A | N/A |
RF Industries Ltd. (RFIL) | 0.01% | $28.760M | -34.35% | 24.43% | 0.82x |
Modular Medical, Inc. (MODD) | 0.01% | $29.612M | N/A | N/A | N/A |
Airgain, Inc. (AIRG) | 0.01% | $31.018M | -28.66% | 38.23% | 0.46x |
Oncternal Therapeutics, Inc. (ONCT) | <0.01% | $20.386M | -53.14% | 58.10% | -33.80x |
Ryvyl, Inc. (GBOX) | <0.01% | $19.036M | 64.45% | 19.55% | 0.37x |
Telesis Bio, Inc. (DNAY) | <0.01% | $11.996M | -16.64% | 43.06% | 2.27x |
Presidio Property Trust, Inc. (SQFT) | <0.01% | $12.124M | 5.66% | 36.89% | 6.37x |
Ainos, Inc. (AIMD) | <0.01% | $11.973M | -98.61% | -5,283.42% | 13.61x |
Organovo Holdings, Inc. (ONVO) | <0.01% | $10.605M | -100.00% | N/A | 13.27x |
Nuvve Holding Corp. (NVVE) | <0.01% | $7.556M | 440.98% | 9.01% | 0.21x |
DMK Pharmaceuticals Corp. (ADMP) | <0.01% | $6.160M | -99.40% | -3,658.77% | -0.39x |
Aethlon Medical, Inc. (AEMD) | <0.01% | $5.235M | N/A | N/A | -6.08x |
TRACON Pharmaceuticals, Inc. (TCON) | <0.01% | $6.447M | N/A | N/A | -0.13x |
Revelation Biosciences, Inc. (REVB) | <0.01% | $3.841M | N/A | N/A | N/A |
Dermata Therapeutics, Inc. (DRMA) | <0.01% | $2.392M | N/A | N/A | N/A |
Histogen, Inc. (HSTO) | <0.01% | $1.538M | N/A | -1,140.00% | -195.09x |
Evofem Biosciences, Inc. (EVFM) | <0.01% | $0.751M | -19.76% | 61.33% | 11.76x |
Kintara Therapeutics, Inc. (KTRA) | <0.01% | $0.966M | N/A | N/A | N/A |
Biocept, Inc. (BIOC) | <0.01% | $0.164M | -94.45% | -332.94% | 0.24x |